ISSN: 2960-1959
Publisher
Original Articles

Benign Tumor Publication in One Year (2022): A Cross-Sectional Study

College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq
King Abdullah Medical City, Makkah, Saudi Arabia
College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq
College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq
College of Science, University of Sulaimani, Sulaimani, Kurdistan, Iraq
Department of Biology, College of Education, University of Sulaimani, Sulaimani, Kurdistan, Iraq

Abstract

Introduction

A benign tumor is a form of abnormal cell proliferation that remains confined to its site of origin, grows slowly, does not spread to distant body parts, nor does it invade the surrounding local structures. In this study, we aim to evaluate and list the scientific publications regarding benign tumors in the year 2022.

Methods

A cross-sectional study was conducted, including the published papers on benign tumors in the year 2022. The data were collected online from the Google Scholar search engine and recorded in Microsoft Excel 2010. The extracted data were calculated and thoroughly re-evaluated, then presented as frequencies and percentages.

Results

A total of 17,007 medical studies were included in this report, with the brain having 3,450 (20.3%) studies, making it the organ with the most studies, whereas the hypopharyngeal portion of the throat had only one study and is, hence, the least studied one.

Conclusion

There is limited reporting and data available on benign tumors, and they are very scattered, leading to either a lack of or a misunderstanding of the burden they pose.

References

  1. Amisha, Patel A. Benign vs malignant tumors. JAMA oncology. 2020;6(9):1488-.90. doi:10.1001/jamaoncol.2020.2592
  2. Zana H. Mahmood, Fenk M. Mohemed, Binaiy N. Fatih, Abdullah A. Qadir and Shalaw H. Abdalla. Cancer publications in one year (2022); a cross-sectional study. Barw Medical Journal. 2023;1(2). doi:10.58742/bmj.v1i2.30
  3. White SC, Pharoah MJ. Oral radiology: principles and interpretation. Seventh. St. Louis, Missouri: Elsevier; 2014. ISBN:978-0-323-09633-1. DOI: N/A
  4. Braem C, Declercq J, Van de Ven W. Molecular biology of benign tumours. InInternational Congress Series 2005 (Vol. 1279, pp. 168-169). doi:10.1016/j.ics.2004.12.062
  5. Yoshihara MK, Lui F. Neuroanatomy, Bitemporal Hemianopsia. InStatPearls [Internet] 2023. StatPearls Publishing. DOI: N/A
  6. Natroshvili T, Peperkamp K, Malyar MA, Wijnberg D, Heine EP, Walbeehm ET. Rare Tumors Causing Median Nerve Compression in Adults—A Narrative Review. Archives of Plastic Surgery. 2022;49(05):656-62. doi:10.1055/s-0042-1756345
  7. Gore RM, Levine MS. High Yield Imaging Gastrointestinal E-Book. Elsevier Health Sciences; 2010. ISBN:978-1-4160-5544-0
  8. McCarthy BJ, Schellinger KA, Propp JM, Kruchko C, Malmer B. A case for the worldwide collection of primary benign brain tumors. Neuroepidemiology. 2009;33(3):268-75.doi:10.1159/000230808
  9. Muhialdeen AS, Ahmed JO, Baba HO, Abdullah IY, Hassan HA, Najar KA, et al. Kscien’s List; A New Strategy to Discourage Predatory Journals and Publishers (Second Version). Barw Medical Journal. 2023; 1(1):30-32. doi:10.58742/bmj.v1i1.17.
  10. Flores LP, Carneiro JZ. Peripheral nerve compression secondary to adjacent lipomas. Surgical neurology. 2007;67(3):258-62. doi:10.1016/j.surneu.2006.06.052
  11. Stuart A. Benign Tumors: Types, Causes, and Treatments [Internet]. WebMD. Available from: https://www.webmd.com/a-to-z-guides/benign-tumors-causes-treatments#:~:text=Treatment%20of%20Benign%20Tumors
  12. Wanner M, Rohrmann S, Korol D, Shenglia N, Gigineishvili T, Gigineishvili D. Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country. Journal of neuro-oncology. 2020; 149:273-82. doi:10.1007/s11060-020-03595-5
  13. Bhala S, Stewart DR, Kennerley V, Petkov VI, Rosenberg PS, Best AF. Incidence of benign meningiomas in the United States: current and future trends. JNCI Cancer Spectrum. 2021;5(3): pkab035. doi:10.1093/jncics/pkab035
  14. Nakamura H, Makino K, Yano S, Kuratsu JI, Kumamoto Brain Tumor Research Group. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan—20-year study. International journal of clinical oncology. 2011; 16:314-21. doi:10.1007/s10147-010-0178-y
  15. Cea-Soriano L, Wallander MA, García Rodríguez LA. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology. 2012;39(1):27-34. doi:10.1159/000338081
  16. Dobes M, Khurana VG, Shadbolt B, Jain S, Smith SF, Smee R et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): findings of a multicenter Australian study. Surgical neurology international. 2011;2. doi:10.4103/2152-7806.90696
  17. Meningiomas – Classifications, Risk Factors, Diagnosis and Treatment [Internet]. www.aans.org. Available from: https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Meningiomas
  18. Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: a review. Jama. 2022; 327(3):264-73. doi:10.1001/jama.2021.24287
  19. Bagheri R, Haghi SZ, Dalouee MN, Nasiri Z. Evaluation of the results of surgery treatment in patients with benign lung tumors. Lung India: Official Organ of Indian Chest Society. 2015;32(1):29. doi:10.4103/0970-2113.148436
  20. Mimoun C, Fritel X, Fauconnier A, Deffieux X, Dumont A, Huchon C. Epidemiology of presumed benign ovarian tumors. Journal de gynecologie, obstetrique et biologie de la reproduction. 2013 ; 42(8) :722-9. doi:10.1016/j.jgyn.2013.09.027
  21. Matalliotakis M, Matalliotaki C, Krithinakis K, Laliotis A, Kapetanios G, Tsakiridis I, et al. Anatomic Distribution of Benign Ovarian Tumors in Perimenopausal and Postmenopausal Women. Cureus. 2023;15(1). doi:10.7759/cureus.34059
  22. Brun JL, Fritel X, Aubard Y, Borghese B, Bourdel N, Chabbert-Buffet N, et al. Management of presumed benign ovarian tumors: updated French guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014; 183:52-8. doi:10.1016/j.ejogrb.2014.10.012
  23. Oldhafer KJ, Habbel V, Horling K, Makridis G, Wagner KC. Benign liver tumors. Visceral medicine. 2020;36(4):292-303. doi:10.1159/000509145
  24. Mergo PJ, Ros PR. Benign lesions of the liver. Radiologic Clinics of North America. 1998;36(2):319-31. doi:10.1016/S0033-8389(05)70025-7
  25. Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma-review. Journal of medicine and life. 2015;8(Spec Issue):4. DOI: N/A
  26. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'alessandro N, Montalto G. Sex hormones and risk of liver tumor. Annals of the New York Academy of Sciences. 2006;1089(1):228-36. doi:10.1196/annals.1386.044
  27. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. Jama. 1979;242(7):644-8. doi:10.1001/jama.1979.03300070040020
  28. Liu Q, Liu F, Ding J, Wei Y, Li B. Surgical outcomes and quality of life between laparoscopic and open approach for hepatic hemangioma: a propensity score matching analysis. Medicine. 2019;98(6). doi:10.1097/MD.0000000000014485
  29. Russo P, Uzzo RG, Lowrance WT, Asnis-Alibozek A, LaFrance ND, Libertino JA, et al. Incidence of benign versus malignant renal tumors in selected studies. Journal of Clinical Oncology. 2012;30(5_suppl):357-. doi:10.1200/jco.2012.30.5_suppl.357
  30. Vijay V, Vokshi FH, Smigelski M, Nagpal S, Huang WC. Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma. Clinical Genitourinary Cancer. 2023;21(3):e114-8. doi:10.1016/j.clgc.2022.11.006
  31. American Cancer Society. Cancer Facts &Figures. 2014. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2014.html
  32. Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME. Management of renal masses and localized renal cancer [Internet]. DOI: N/A
  33. Gressner AM, Gressner OA. Robert Koch-Institut. InLexikon der Medizinischen Laboratoriumsdiagnostik 2019 (pp. 2078-2079). Berlin, Heidelberg: Springer Berlin Heidelberg.doi:10.1007/978-3-662-48986-4_2709
  34. Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Deutsches Ärzteblatt International. 2019;116(33-34):565. doi:10.3238/arztebl.2019.0565
  35. Paepke S, Metz S, Brea Salvago A, Ohlinger R. Benign breast tumours-diagnosis and management. Breast Care. 2018;13(6):403-12. doi:10.1159/000495919.
  36. Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J, Bogucevska M, Dobruch-Sobczak K. Fine-needle versus core-needle biopsy–which one to choose in preoperative assessment of focal lesions in the breasts? Literature review. Journal of ultrasonography. 2017;17(71):267-74. doi:15557/JoU.2017.0039

Send mail to Author


Send Cancel
Themes by Openjournaltheme.com